Mitochondria-made peptides emerge as preclinical analgesic candidates
Preclinical studies show the mitochondrial peptides humanin and MOTS-c reduce pain across multiple animal models by restoring mitochondrial function, suppressing ...
Preclinical studies show the mitochondrial peptides humanin and MOTS-c reduce pain across multiple animal models by restoring mitochondrial function, suppressing ...
A rat and cell study finds empagliflozin eased isoproterenol-induced myocardial injury through PGC-1α-driven mitochondrial biogenesis and fatty acid utilization.
A combination of low-dose metformin and valproic acid reprograms the metabolism of drug-tolerant persister cells in gastric and liver cancer ...
In diabetic rats, oral papain supplementation improved renal bioenergetic, antioxidant and inflammatory markers and raised PGC-1α gene expression, performing comparably ...
A new review synthesizes genetic and epigenetic evidence showing that endurance performance is a polygenic, dynamically regulated trait shaped by ...
Three commercially approved metabolism-targeting drugs—pioglitazone, melatonin and insulin—improved survival, motor function, muscle size and hepatic pathology in Smn2B/- spinal muscular ...
A four-week trial of nicotinamide riboside in eight patients with mitochondrial DNA disease shows the first human evidence of molecular ...
A study in Experimental & Molecular Medicine shows that the N-terminal fragment of thrombospondin-1 enhances muscle function and drives tissue-specific ...
A single N-terminal amino acid removed during mitochondrial protein maturation globally stabilizes the organelle's protein complexes, revealing a new layer ...
New research shows the plant lignan syringaresinol activates the skeletal muscle SIRT1–PGC-1α–FNDC5/irisin axis in cells and high-fat-diet-fed mice, reducing weight ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine